A report published by the Department of Health and Human Services that suggests a connection between gender-affirming care and left-wing authoritarianism is facing sharp criticism from health policy experts, who question both the quality of its research and the political motivations behind it.
The document, titled "Where the Clinic Meets the Movement: Does Gender Ideology Arm Left-Wing Authoritarian Psychology?," was released without undergoing peer review, a standard practice for scientific research that involves independent evaluation by other experts in the field. The report's underlying data and information about its funding have also not been made public, though one of its authors has said the data will be shared at a later date.
The publication represents the most recent in a series of actions by HHS that critics say are intended to weaken confidence in established medical standards of care for transgender individuals. Numerous experts who were interviewed about the report said it presents transgender identity as something illegitimate or potentially threatening.
Among the report's authors is Colin Wright, an evolutionary biologist affiliated with the Manhattan Institute, a conservative policy organization that has actively campaigned against diversity, equity and inclusion programs and initiatives described by critics as "woke." The involvement of a figure from a politically oriented think tank has raised questions about the objectivity of the research.
Adrian Shanker, who previously served as a deputy assistant secretary for health policy at HHS during the Biden administration, said that while collaboration with outside experts is not unusual for the department, the nature of those partnerships has traditionally been different. He explained that HHS had long-standing agreements with generalist science writing firms that maintained a nonpolitical approach to their work. Shanker described the current situation as vastly different from that established practice.
The timing and framing of the report fit into a broader pattern that has emerged under the current administration. Since President Trump announced Robert F. Kennedy Jr. as his choice to lead HHS last year, both men have repeatedly emphasized their commitment to what they call "Gold Standard Scientific Research" and to transforming federal health agencies into models of transparency. The release of a non-peer-reviewed report with undisclosed data appears to conflict with those stated goals, according to experts who spoke about the matter.
Peer review is widely regarded as a fundamental component of credible scientific publishing. It involves subjecting a study's methods, data and conclusions to scrutiny by independent specialists before publication, helping to identify errors, biases or unsupported claims. The absence of this step in the HHS report has led researchers to question how much confidence the public should place in its findings.
Transparency regarding data and funding is also considered essential in research, particularly when the subject matter carries significant public health implications. The fact that the report's data has not yet been released makes it difficult for independent scientists to verify its claims or attempt to reproduce its results. The promise that the data will be available "soon" does little to address immediate concerns about the report's reliability.
The report's central assertion — that gender-affirming care may be connected to radicalization and political violence — arrives amid an ongoing national debate over transgender rights and access to medical treatment. Gender-affirming care encompasses a range of services, including counseling, hormone therapy and surgical procedures, that are supported by major medical organizations such as the American Medical Association and the American Academy of Pediatrics.
For years, these institutions have maintained that gender-affirming care is medically necessary for many transgender individuals and that it is supported by decades of clinical experience and research. Efforts by HHS to cast doubt on these standards have alarmed health care providers and advocates, who worry that such reports could be used to justify policy changes restricting access to care.
Experts interviewed for this story suggested that the report's framing serves a specific purpose: to portray transgender people as a threat rather than as a vulnerable population deserving of medical support. By linking gender-affirming care to political extremism, the report may contribute to a climate in which discriminatory policies appear justified.
The involvement of the Manhattan Institute, which has a history of opposing progressive social initiatives, further complicates the report's credibility. While HHS is permitted to consult with external experts, the selection of researchers from advocacy-oriented organizations can introduce ideological bias into what should be an impartial scientific process.
Shanker's comparison between past and present practices highlights a shift in how the department engages with outside researchers. Under previous administrations, contracts with science writing firms were designed to ensure that reports met professional standards and remained free from political influence. The current approach, according to Shanker, deviates significantly from that tradition.
Critics argue that the report is part of a coordinated effort to erode public trust in medical institutions that serve transgender patients. If federal agencies release findings that appear politically motivated, patients, families and clinicians may become uncertain about which guidance to follow. This uncertainty can have real consequences for people seeking care.
The report also raises questions about the role of federal health agencies in shaping public discourse. When agencies publish research that lacks standard safeguards, they risk damaging their own reputation for objectivity. Once that trust is lost, it can be difficult to restore, even when future reports are conducted properly.
For transgender individuals and their supporters, the release of such a document is not merely an academic matter. It contributes to an environment in which their identities are debated in political terms rather than treated as matters of health and well-being. Advocacy groups have consistently argued that transgender people are not dangerous and that framing them otherwise contributes to stigma and discrimination.
As the department continues to pursue its agenda, researchers and policy experts say they will be watching closely to see whether the promised data materializes and whether future reports adhere to established scientific norms. Until then, the report's conclusions remain unverified and its methods open to challenge. The broader question — whether federal health agencies will prioritize evidence-based research over political messaging — remains unanswered.
(0)